Law360 (November 20, 2020, 7:01 PM EST) -- The Seventh Circuit affirmed Thursday a former pharmacy CEO's 33-month prison sentence after a jury found him guilty of knowingly selling mislabeled opioids and other drugs, including some that were nearly 25 times stronger than advertised and threatened the lives of infants.
In an 11-page opinion, a three-judge panel unanimously ruled the district court did not abuse its discretion in admitting evidence in Pharmakon Pharmaceutical CEO Paul Elmer's trial or adding more time to his prison sentence, as the victims of his criminal conduct were infants and particularly vulnerable.
In fact, the panel said the former CEO's sentence "was more than...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!